In an analysis that included nearly 300,000 patients from eight states who underwent ambulatory surgery, researchers found that the rates of surgical site infections were relatively low; however, the absolute number of patients with these complications is substantial, according to a study in the February 19 issue of JAMA.
Â
Surgical site infections are among the most common healthcare-associated infections, accounting for 20 percent to 31 percent of healthcare-associated infections in hospitalized patients, according to background information in the article. Although ambulatory surgeries represent a substantial portion of surgical healthcare, there is a lack of information on adverse events, including healthcare-associated infections.
Â
Pamela L. Owens, PhD, of the Agency for Healthcare Research and Quality (AHRQ) in Rockville, Md., and colleagues determined the incidence of clinically significant surgical site infections (CS-SSIs) following low- to moderate-risk ambulatory surgery in patients with low risk for surgical complications (defined as not seen in past 30 days in acute care, length of stay less than two days, no other surgery on the same day, and discharged home and no infection coded on the same day). The researchers used the 2010 Healthcare Cost and Utilization Project State Ambulatory Surgery and State Inpatient Databases for eight states (California, Florida, Georgia. Hawaii. Missouri, Nebraska, New York, and Tennessee), representing one-third of the U.S. population. The analysis included 284,098 ambulatory surgical procedures (general surgery, orthopedic, neurosurgical, gynecologic, and urologic) in adult patients; rates were calculated for 14- and 30-day postsurgical acute care visits for CS-SSIs following ambulatory surgery.
Â
The researchers found that the overall rate of postsurgical acute care visits within 14 days for CS-SSIs was relatively low (3.09 per 1,000 ambulatory surgical procedures). When the time frame was extended to 30 days, the rate increased to 4.84. Two-thirds (63.7 percent) of all visits for CS-SSI occurred within 14 days of the surgery; of those visits, 93.2 percent involved treatment in the inpatient setting.
Â
The authors note that although the overall rate of CS-SSIs was low, because of the large number of ambulatory surgical procedures performed annually, in absolute terms, a substantial number of patients develop clinically significant postoperative infections. Most of these infections occurred within two weeks after surgery and resulted in hospital admission. Our findings suggest that earlier access to a clinician or member of the surgical team (e.g., telephone check-in prior to two weeks) may help identify and treat these infections early and reduce overall morbidity.
Â
Prior studies showing significant lapses in infection control practices at ambulatory surgery centers suggest that quality improvement efforts may facilitate reducing CS-SSIs following ambulatory surgery, the authors write.
Â
This study was funded by the Agency for Healthcare Research and Quality under a contract to Truven Health Analytics to develop and support the Healthcare Cost and Utilization Project.
Source: JAMA
Together We Rise: Why AORN Expo 2025 Is a Must for Every Perioperative Nurse
March 31st 2025From April 5 to 8, 2025, thousands of perioperative nurses will gather in Boston for the 2025 AORN Global Surgical Conference & Expo—a transformational experience designed to elevate nursing practice, build lifelong connections, and advance surgical care.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.